icer semaglutide Pricing group says weight-loss drugs becoming more cost-effective ICER ups value ceiling for

A leaner market: GLP-1 weight loss drugs and the future of red meat demand Tuesday, 5 May 2026 As more people begin to take GLP-1 weight loss drugs, what influence could this have on the red meat industry

Two-year effects of semaglutide in adults with overweight or obesity (STEP-5)

Delayed stomach emptying can cause nausea, vomiting, constipation or heartburn, especially when starting the medication or increasing the dose

This creates a supportive network that maintains cellular balance

Phase 2 obesity data published in The New England Journal of Medicine showed large average weight reductions, which helped establish retatrutide as one of the most closely watched next-generation obesity drugs in development